A. Profile
Slgirim Lee, Ph.D.
Manager
Research Strategy Team
Inventage Lab Inc.
9F, U-Space 2B, 670, Daewangpangyo-ro,
Bundang-gu, Seongnam-si, Gyeonggi-do, Korea
* Detailed CV is attached as a pdf file at the end of this page
Educational Background
Ph.D Dept. of Chemical and Biomolecular Engineering,
College of Engineering, Yonsei University, Seoul, Korea
Graduate research with Prof. Jae-Hyung Jang
Thesis: "The strategies for fabrication of three-dimensional electrospun scaffolds delivering stem cells and gene vectors"
B.S. Dept. of Chemical and Biomolecular Engineering
Yonsei University, Seoul, Korea
Gyeonggi Science High School for the Gifted (Science Academy), Korea
Work Experiences
2023 ~ : Manager, Research Strategy Team
Inventage Lab Inc, Seongnam-si, Korea2021 ~ 2023 : Research Professor, Nano Science Technology Institute
Yonsei University, Seoul, Korea2019 ~ 2021 : Technology Analyst, Manager, New Business Development
SK Bioscience, Korea
2017 ~ 2019 : Post-doctoral Fellow, Simpson Querrey Institute
Northwestern University, Chicago, IL (Advisor: Prof. Samuel I. Stupp)
2016 ~ 2017 : Post-doctoral researcher, Engineering Research Institute
Yonsei University, Seoul, Korea (Advisor: Prof. Jae-Hyung Jang)
2016 : Visiting Researcher, Department of Chemical Engineering
University of California, Berkeley, CA, United States (Prof. David V. Schaffer)
Involved Research Projects
Center for Bio-inspired Energy Science (CBES), Northwestern University
Center for Regenerative Nanomedicine (CRN), Northwestern University
Funds from National Research Foundation (NRF) of Korea
Development of adeno-associated virus-based gene delivery systems for specifically targeting human immune cells
Development of 3D complex patterns from conducting polymer nanofibers
Development of elastic, injectable and self-assembling multi-layered smart nanofibrous scaffolds for spinal cord regeneration
Development of spatiotemporal tissue control system by spatial and temporal delivery of sticky gene vectors
Funds from Ministry of Health and Welfare of Korea
Protocol development of human neural stem cell specific adeno-associated virus based cell-gene therapy for spinal cord injury treatment
Establishment of clinical trial protocol for gene-cell therapies using a human neural stem cell specific “brand-new” adeno-associated viral vector (AAV r3.45)
Research Skills
Intensive experience in polymeric engineering to produce nanofibrous matrices with a variety of micro- and macroscopic properties
Extensive research experience for developing cell and gene delivery systems:
material science, genomic cloning, in vitro experiments and animal studies
Material Science / Polymer Engineering
Electrospinning / post-electrospinning modification
Hydrogel fabrication
Polymer composites
Polymer modification / synthesis / purification
Peptide amphiphile (PA) synthesis / purification (HPLC, MassSpec) / engineering
Characterization of mechanical (tensile, compressive and adhesive strength), rheological and chemical (NMR, IR) properties of polymeric structures
Imaging including SEM, fluorescent microscopy, confocal laser scanning microscopy, etc.
Cloning, In Vitro and In Vivo Studies
AAV production / purification / transduction
Cloning, transformation, and plasmid prep
Cell line, and human neural stem cell culture
Characterization of in vitro cell viability, and transduction efficiency (FACS analysis)
Implantation surgery and characterization (immunostaining and IVIS analysis)
Awards and Honors
National Science & Technology Scholarship awards
Undergraduate Research Project (URP) from Korea Foundation
for the Advancement of Science and Creativity (KOFAC)
Global Ph.D Fellowship, National Research Foundation (NRF) of Korea
The article published in ACS Appl. Mater. Interfaces was highlighted
at Global Medical Discovery, Key Nanotechnology Article
Selected as People who has brought great honor to Korea
(한국을 빛내는 사람들), Biological Research Information Center (BRIC) (2016.02.)
Selected as People who has brought great honor to Korea
(한국을 빛내는 사람들), Biological Research Information Center (BRIC) (2017.08.)